BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25474298)

  • 1. Osteonecrosis of the jaw in a patient receiving cabozantinib.
    Marino R; Orlandi F; Arecco F; Gandolfo S; Pentenero M
    Aust Dent J; 2015 Dec; 60(4):528-31. PubMed ID: 25474298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jaw osteonecrosis related to cabozantinib.
    Sánchez López JD; Rodríguez Ruiz JA; Miguel PPT
    Med Clin (Barc); 2021 Jun; 156(12):627-628. PubMed ID: 32883509
    [No Abstract]   [Full Text] [Related]  

  • 4. Sunitinib related osteonecrosis of jaw: a case report.
    Fleissig Y; Regev E; Lehman H
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Mar; 113(3):e1-3. PubMed ID: 22676833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avascular osteonecrosis of the mandible following bisphosphonate therapy.
    Chandra PA; Chandra AB; Todd GK
    Am J Ther; 2009; 16(1):65-7. PubMed ID: 22573056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jaw avascular osteonecrosis after treatment of multiple myeloma with zoledronate.
    Lobato JV; Maurício AC; Rodrigues JM; Cavaleiro MV; Cortez PP; Xavier L; Botelho C; Hussain NS; Santos JD
    J Plast Reconstr Aesthet Surg; 2008; 61(1):99-106. PubMed ID: 18068658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone regeneration without bone grafting after resection of a segment of the mandible to treat bisphosphonate-related osteonecrosis of the jaw.
    Wilde F; Hendricks J; Riese C; Pausch NC; Schramm A; Heufelder M
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2657-62. PubMed ID: 21741741
    [No Abstract]   [Full Text] [Related]  

  • 8. Sore mandible. Bisphosphonate-associated osteonecrosis.
    Damm DD; Fantasia JE
    Gen Dent; 2006; 54(5):370, 372. PubMed ID: 17004575
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteonecrosis of the jaw related to everolimus: a case report.
    Kim DW; Jung YS; Park HS; Jung HD
    Br J Oral Maxillofac Surg; 2013 Dec; 51(8):e302-4. PubMed ID: 24094895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases.
    Hoefert S; Eufinger H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):463-9. PubMed ID: 20692189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteonecrosis associated with short-term oral administration of bisphosphonate.
    Takagi Y; Sumi Y; Harada A
    J Prosthet Dent; 2009 May; 101(5):289-92. PubMed ID: 19410063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mandibular Osteonecrosis Associated With Raloxifene.
    Pontes HAR; Souza LL; Uchôa DCC; Cerqueira JMM
    J Craniofac Surg; 2018 May; 29(3):e257-e259. PubMed ID: 29303860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
    Hay KD; Bishop PA
    N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
    Infante Cossío P; Cabezas Macián A; Pérez Ceballos JL; Palomino Nicas J; Gutiérrez Pérez JL
    Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E52-7. PubMed ID: 18167482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denosumab-related osteonecrosis of the jaw.
    Diz P; López-Cedrún JL; Arenaz J; Scully C
    J Am Dent Assoc; 2012 Sep; 143(9):981-4. PubMed ID: 22942143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate-associated osteonecrosis of the jaw: a six-year history of a case.
    Hewson ID
    N Z Dent J; 2011 Sep; 107(3):97-100. PubMed ID: 21957837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronate-related osteonecrosis of the mandible.
    Ho L; Quan V; Henderson R
    Clin Nucl Med; 2008 Jan; 33(1):68-70. PubMed ID: 18097268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis of the mandible due to anti-angiogenic agent, bevacizumab.
    Pakosch D; Papadimas D; Munding J; Kawa D; Kriwalsky MS
    Oral Maxillofac Surg; 2013 Dec; 17(4):303-6. PubMed ID: 23242941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orthodontic treatment of patients using bisphosphonates: a report of 2 cases.
    Rinchuse DJ; Rinchuse DJ; Sosovicka MF; Robison JM; Pendleton R
    Am J Orthod Dentofacial Orthop; 2007 Mar; 131(3):321-6. PubMed ID: 17346586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.